(Q54534530)

31 May 2018

title

Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori. (English)

1 reference

31 May 2018

0 references

0 references

0 references

9

Thomas P Monath

1 reference

31 May 2018

Stavros Sougioultzis

1

1 reference

31 May 2018

Cynthia K Lee

2

1 reference

31 May 2018

Mazen Alsahli

3

1 reference

31 May 2018

Subhas Banerjee

4

1 reference

31 May 2018

Michel Cadoz

5

1 reference

31 May 2018

Robert Schrader

6

1 reference

31 May 2018

Bruno Guy

7

1 reference

31 May 2018

Philip Bedford

8

1 reference

31 May 2018

Ciaran P Kelly

10

1 reference

31 May 2018

Pierre Michetti

11

1 reference

31 May 2018

language of work or name

English

0 references

publication date

1 December 2002

1 reference

31 May 2018

published in

Vaccine

1 reference

31 May 2018

volume

21

1 reference

31 May 2018

issue

3-4

1 reference

31 May 2018

page(s)

194-201

1 reference

31 May 2018

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Antibiotic resistance in Helicobacter pylori: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Therapeutic immunisation against Helicobacter infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

The mucosal immune system: from fundamental concepts to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

The design of vaccines against Helicobacter pylori and their development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Lymphoglandular complexes of the colon: structure and distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Specific immune response in humans following rectal delivery of live typhoid vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Rectal immunization for induction of specific antibody in the genital tract of women

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900467-X

7 January 2021

10.1016/S0264-410X(02)00467-X

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018